(Q33897785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

meta-analysis

0 references

title

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

I M Anderson

series ordinal

1

1 reference

29 July 2017

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

Journal of Affective Disorders

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

19-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Controlled trial of amitriptyline in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine and amitriptyline in the treatment of depression in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Binding of antidepressants to human brain receptors: focus on newer generation compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine and chlorimipramine in endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

An overview of paroxetine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

The importance of accidents in evaluating the cost of SSRIs: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Relative mortality from overdose of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Are SSRIs a cost-effective alternative to tricyclics?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Comparative efficacy of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A comparison of fluoxetine and amitriptyline in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A comparative trial of a new antidepressant, fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Secondary and meta-analysis of the efficacy of non-tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Antidepressant prescribing practices of outpatient psychiatrists.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Severity of depression and response to fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Recognition and management of depression in general practice: consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Comparison of fluoxetine and desipramine in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A comparison of the antidepressant action of citalopram and amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. South Wales Antidepressant Drug Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Are in-patient depressives more often of the melancholic subtype? Danish University Antidepressant Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Comparative effects of fluoxetine and amitriptyline on cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine. A review of its safety profile in world-wide studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900092-0

7 January 2021

10.1016/S0165-0327(99)00092-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760555%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference